Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
NCT ID: NCT00879268
Last Updated: 2009-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
20 participants
INTERVENTIONAL
2004-07-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypothermic Machine Preservation-Phase 2
NCT01274520
Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation
NCT00855712
Study of the PAS-Port® Proximal Anastomosis System in Coronary Bypass Surgery
NCT00355563
Best Cardiac Output During Cardiopulmonary Bypass
NCT01379638
Haemoadsorption During Heart Transplantation
NCT05270902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
Utilization of Vasosol with Medtronic System for Machine Preservation of the Liver for Liver Transplantation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lab MELD\<35
* Donor age \<65
Exclusion Criteria
* DCD donor liver
* Multi-organ Recipient
* Recipient in ICU
* Retransplant
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Health Resources and Services Administration (HRSA)
FED
Polyak, Maximilian
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Columbia University Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James V. Guarrera, M.D.
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G030132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.